← Browse by Condition
Medical Condition

chemotherapy effect

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for chemotherapy effect sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chemotherapy effect Clinical Trials

How many clinical trials are currently recruiting for chemotherapy effect?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for chemotherapy effect, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chemotherapy effect?
chemotherapy effect research spans Phase 2 (2 trials), Phase 3 (5 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chemotherapy effect clinical trial?
Eligibility criteria for chemotherapy effect trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Phase 3
5
Top Sponsors
Sixth Affiliated Hospital, Sun Yat-sen University 2 trials
Hunan Cancer Hospital 1 trial
Instituto Nacional de Cancerologia de Mexico 1 trial
Amsterdam UMC, location VUmc 1 trial
University of Alabama at Birmingham 1 trial

Recruiting Clinical Trials

NCT05326295
Recruiting
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Enrollment
1,000 pts
Location
China
Sponsor
Hunan Cancer Hospital
View Trial →
NCT03275194 Phase 2
Recruiting
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Enrollment
100 pts
Location
Mexico
Sponsor
Instituto Nacional de Cancerol...
View Trial →
NCT05861505 Phase 3
Recruiting
COLLISION RELAPSE Trial
Enrollment
360 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc
View Trial →
NCT06510010 Phase 2
Recruiting
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Enrollment
198 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT05864274
Recruiting
Improve Cancer-related Cognitive Impairment
Enrollment
64 pts
Location
United States
Sponsor
University of Alabama at Birmi...
View Trial →
NCT04821843 Phase 3
Recruiting
Neoadjuvant Treatment Modalities in Esophageal Cancer
Enrollment
2,000 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT05815082 Phase 3
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
Enrollment
490 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT06172205 Phase 3
Recruiting
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
Enrollment
262 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
View Trial →
NCT05983783 Phase 3
Recruiting
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC
Enrollment
200 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT06944587
Recruiting
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Enrollment
400 pts
Location
Norway
Sponsor
Oslo University Hospital
View Trial →

Related Conditions

colorectal cancer (2) liver metastases (2) surgery (2) breast neoplasms (1) neoplastic cells circulating (1) hpec (1) ovarian cancer (1) women s health neoplasm of ovary (1) liver metastasis colon cancer (1) recurrence (1) gynecologic cancer (1) chemo brain (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology